Evidence map›Paper›PMID 36306801›Full record

ArticleThe lancet. Gastroenterology & hepatology2022

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease.

Joshua Quan, Christopher Ma, Remo Panaccione, Lindsay Hracs, Nastaran Sharifi, Michelle Herauf, Ante Markovinović, Stephanie Coward, Joseph W Windsor, Léa Caplan and 11 more

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The lancet. Gastroenterology & hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD.Journal of the Canadian Association of Gastroenterology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Joshua QuanInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Christopher MaInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Remo PanaccioneInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Lindsay HracsInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Nastaran SharifiInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Michelle HeraufInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Ante MarkovinovićInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Stephanie CowardInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Joseph W WindsorInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Léa CaplanInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Richard J M IngramInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada.
Carmen CharltonDepartment of Medicine, Department of Medical Microbiology and Immunology, Li Ka Shing Institute of Virology, University of Calgary, Calgary, AB, Canada; Alberta Precision Laboratories, Public Health Laboratory, Calgary, AB, Canada.
Jamil N KanjiDivision of Infectious Diseases, University of Calgary, Calgary, AB, Canada; Alberta Precision Laboratories, Public Health Laboratory, Calgary, AB, Canada; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
Graham TipplesDepartment of Medicine, Department of Medical Microbiology and Immunology, Li Ka Shing Institute of Virology, University of Calgary, Calgary, AB, Canada; Alberta Precision Laboratories, Public Health Laboratory, Calgary, AB, Canada.
Jessalyn K HolodinskyDepartment of Clinical Neuroscience, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Charles N BernsteinIBD Clinical and Research Centre and Department of Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Douglas J MahoneyDepartment of Microbiology, Immunology and Infectious Disease, University of Calgary, Calgary, AB, Canada.
Sasha BernatskyDivision of Rheumatology and Division of Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
Eric I BenchimolICES, Toronto, ON, Canada; SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, ON, Canada; Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Gilaad G KaplanInflammatory Bowel Disease Clinic, University of Calgary, Calgary, AB, Canada. Electronic address: ggkaplan@ucalgary.ca.
STOP COVID-19 in IBD Research Group
University of Calgary · CACalgary Laboratory Services · CAMcGill University Health Centre · CASickKids Foundation · CAUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Inflammatory Bowel DiseasesViral VaccinesCOVID-19 VaccinesHumansSARS-CoV-2COVID-19 VaccinesViral Vaccines

Identifiers

PMID36306801
PMCPMC9597523
OpenAlexW4307402977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.